1-6 of 6
Teng Fang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Novel Indirubin-3-Monoxime Derivative Functions As Regulator of Proteostasis Via Targeting TRIM28 in Multiple Myeloma

Teng Fang, Hao Sun, Xiyue Sun, Zhen Yu, Xiaoyu Zhang, Lanting Liu, Lixin Gong, Shiyi Xie, Mu Hao, Lugui Qiu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6572.
https://doi.org/10.1182/blood-2023-180712
Published: 2023
Journal Articles

High Level of IL-16 Secreted By Non-GCB DLBCL Facilitates Tumor Growth Though the Tumor-Promoting and Immunosuppressive Tumor Microenvironment

Xuwen Guan, Teng Fang, Yi Wang, Wei Liu, Mu Hao, Lugui Qiu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6080.
https://doi.org/10.1182/blood-2023-180840
Published: 2023
Journal Articles

Single-Cell Transcriptome Profiling Reveals Tumor Cell Heterogeneity and Immunosuppressive Microenvironment in Waldenström Macroglobulinemia

Hao Sun, Teng Fang, Tingyu Wang, Zhen Yu, Lixin Gong, Xiaojing Wei, Lugui Qiu, Mu Hao
Journal: Blood
Blood (2022) 140 (Supplement 1): 11872.
https://doi.org/10.1182/blood-2022-164483
Published: 2022
Journal Articles

Multiple Myeloma-Derived Mir-27b-3p Facilitates Tumor Progression Via Promoting Tumor Cell Proliferation and Immunosuppressive Microenvironment

Xiaojing Wei, Zhen Yu, Hao Sun, Lixin Gong, Lanting Liu, Teng Fang, Yi He, Tingyu Wang, Weiwei Sui, Yan Xu, Gang An, Xiaoke Ma, Lugui Qiu, Mu Hao
Journal: Blood
Blood (2022) 140 (Supplement 1): 7106–7107.
https://doi.org/10.1182/blood-2022-156759
Published: 2022
Journal Articles

Exosome Mirnas Profiling in Serum and Prognostic Evaluation in Patients with Multiple Myeloma

Teng Fang, Hao Sun, Mu Hao, Lugui Qiu
Journal: Blood
Blood (2022) 140 (Supplement 1): 12474–12475.
https://doi.org/10.1182/blood-2022-162902
Published: 2022
Journal Articles

Preliminary Results from a Multicenter, Single-Arm, Phase 2 Study of CS1001, an Anti-Programmed Death-Ligand 1 (PD-L1) Human Monoclonal Antibody (mAb), in Patients (pts) with Relapsed or Refractory Extranodal Natural Killer/T Cell Lymphoma (rr-ENKTL)

Hui-qiang Huang, MD PhD, Rong Tao, MD PhD, Liqun Zou, Hong Cen, MD PhD, Ye Guo, MD PhD, Yunhong Huang, MD PhD, Wenbin Qian, MD PhD, Liling Zhang, MD PhD, Hui Zhou, MD PhD, Yu Yang, MD PhD, Haiyan Yang, Dan Zhu, Teng Fang, PhD, Hangjun Dai, Yueling Wang, Jianxin Yang, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2833.
https://doi.org/10.1182/blood-2019-121865
Published: 2019